Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Financial Expert Downgrades Runway Growth Finance Corp from Overweight to Neutral

Elaine Mendonca by Elaine Mendonca
March 8, 2024
in Breaking News
0
Finance_Business (2)
0
SHARES
20
VIEWS
Share on FacebookShare on Twitter

On March 8, 2024, financial expert Melissa Wedel from JP Morgan made the decision to downgrade Runway Growth Finance Corp. (NASDAQ: RWAY) from an Overweight rating to Neutral. Additionally, she adjusted the price target for the company from $13.5 to $12.5. This change in rating signifies a change in Wedel’s outlook on the company’s trajectory and potential for expansion.

RWAY Stock Analysis: Volatile Movements on March 8, 2024 – Stay Informed and Monitor Closely

On March 8, 2024, RWAY stock showed some interesting movements in its performance. According to data from CNN Money, RWAY was trading near the top of its 52-week range and above its 200-day simple moving average. The price of RWAY shares increased by $0.17 since the market last closed, representing a 1.28% rise. The stock closed at $13.50, showing a positive movement from the previous trading session. However, things took a turn in pre-market trading as the stock dropped by $1.61. Investors should pay attention to these pre-market movements as they can often set the tone for the trading day ahead. Overall, RWAY stock showed some volatility on March 8, 2024, with both positive and negative movements. Investors should continue to monitor the stock closely and stay informed about any news or developments that could impact its performance.

RWAY Stock Performance Analysis: Revenue Grows, Net Income Declines

On March 8, 2024, RWAY stock experienced mixed performances based on the financial data provided by CNN Money. The company’s total revenue for the past year stood at $107.49 million, showing a significant increase of 42.31% compared to the previous year. However, in the third quarter of the fiscal year, total revenue dropped to $43.78 million, although it still managed to increase by 4.5% from the previous quarter.

In terms of net income, RWAY reported a net income of $32.25 million for the past year, reflecting a decrease of 29.31% from the previous year. In the third quarter, the net income further declined to $14.82 million, marking a 33.59% decrease from the previous quarter.

Earnings per share (EPS) also took a hit for RWAY stock. The EPS for the past year was $0.79, which represents a 31.69% decrease from the previous year. In the third quarter, EPS dropped to $0.37, showing a 33.59% decrease from the previous quarter.

Overall, RWAY stock faced challenges in terms of net income and EPS, with both indicators experiencing a significant decline compared to the previous year and quarter. However, the company managed to achieve growth in total revenue, albeit at a slower pace in the third quarter.

Tags: RWAY
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biopharmaceutical Stock Market Today (1)

FDA Requests Further Information on Donanemab Delays Decision Timeline

DrugRetailers Stock Bull Market

Analysts Downgrade Victorias Secret Amidst Negative Developments

Finance_Cash

UBS Analyst Downgrades Maxeon Solar Technologies Ltd from Neutral to Sell

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com